Omada Health is making its public-market debut, propelled by Americans’ renewed focus on how weight affects physical health.

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...

GLP-1 drugs alter taste perception… and commonly disrupt the perception of sweetness, bitterness, fatty foods and even ...

As consumers taking medications like Ozempic cut back on eating out, about 70% are spending more on cooking at home, ...

We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should ...

HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments ...

Another challenge is brewing for restaurants. It’s not the economy, another global disease, or a weather disaster. It’s the ...

Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...